Showing results (181-190 of 264) with videos related to

Sort By:
Pageof 27
Plos One|February 1, 2013
The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movementJonathan Savitz, Colin A Hodgkinson, Chantal Martin-Soelch, et al.
Focus (American Psychiatric Publishing)|February 5, 2020
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled StudyCarla M Canuso, Jaskaran B Singh, Maggie Fedgchin, et al.
Biological Psychiatry|April 2, 2013
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography studyPaul J Carlson, Nancy Diazgranados, Allison C Nugent, et al.
Alcoholism, Clinical and Experimental Research|April 3, 2014
Cerebrospinal fluid monocyte chemoattractant protein-1 in alcoholics: support for a neuroinflammatory model of chronic alcoholismJohn C Umhau, Melanie Schwandt, Matthew G Solomon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2024
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled studyMark E Schmidt, Iva Kezic, Vanina Popova, et al.
Brain, Behavior, and Immunity|October 12, 2019
Appetite change profiles in depression exhibit differential relationships between systemic inflammation and activity in reward and interoceptive neurocircuitryKelly T Cosgrove, Kaiping Burrows, Jason A Avery, et al.
The International Journal of Neuropsychopharmacology|May 21, 2013
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorderJonathan Savitz, Colin A Hodgkinson, Chantal Martin-Soelch, et al.
Biological Psychiatry|July 11, 2009
Bcl-2 polymorphism influences gray matter volume in the ventral striatum in healthy humansGiacomo Salvadore, Allison C Nugent, Guang Chen, et al.
Brain, Behavior, and Immunity|November 8, 2015
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorderTimothy B Meier, Wayne C Drevets, Brent E Wurfel, et al.
Brain, Behavior, and Immunity|July 6, 2017
The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's diseaseYu Sun, Dai Wang, Giacomo Salvadore, et al.
Pageof 27